{
    "abstract": "Measles and mumps outbreaks still occur in countries that have successfully implemented universal routine immunization programs. Measles outbreaks are mostly associated to absent or incomplete vaccination, whereas for mumps outbreaks the combined effects of waning of immunity and circulating new strains are incriminated. It is therefore increasingly useful to characterize the long-lasting immunity induced by measles-, mumps, and rubella (MMR)-containing vaccines. In this 10-year study, 1887 healthy children aged 12\u201322 months, randomized to receive 1 or 2 doses of MMR-containing vaccines (Priorix or Priorix-Tetra; GSK), were included in an antibody persistence analysis. A total of 364 children in the 1-dose group received a second dose out of study according to their local vaccination schedule between Years 4 and 10 post-dose 1, and were included in a separate post-hoc analysis to evaluate the effect of the second dose when given later. Anti-measles, -mumps and -rubella antibody titers were measured by commercial ELISA kits (Enzygnost, Siemens) after each vaccine dose and at Years 1, 2, 4, 6, 8 and 10 post-vaccination. Antibodies against measles and rubella declined moderately after vaccination but remained well above the seropositivity threshold after 10 years. The anti-measles antibody titers elicited by Priorix-Tetra remained about 2-fold higher throughout the study as compared with Priorix. A second dose of MMR vaccine later in life had a minor and transient effect on anti-measles and anti-rubella waning titers. In contrast, anti-mumps antibody levels remained relatively stable over the 10-year follow-up and a second dose of MMR vaccine, given anytime over the 10-year period, had a boosting effect on anti-mumps antibody titers and seropositivity rates. In conclusion, 1 or 2 doses of MMR-containing vaccines given to children in their second year of life induced antibody responses against measles, mumps and rubella viruses that persisted at least up to 10 years post-vaccination. Clinical trial registration number: NCT00226499.",
    "author_highlights": [
        {
            "endOffset": 12791,
            "sentence": "Measles-mumps-rubella (MMR)-containing vaccines provide robust immune responses up to 10 years.",
            "startOffset": 12696
        },
        {
            "endOffset": 12886,
            "sentence": "Antibody levels persisted above seropositivity threshold for all three antigens over 10 years.",
            "startOffset": 12792
        },
        {
            "endOffset": 12990,
            "sentence": "Anti-measles antibody titers elicited by Priorix-Tetra remain 2-fold higher than Priorix over 10 years.",
            "startOffset": 12887
        },
        {
            "endOffset": 13084,
            "sentence": "A second dose of a MMR-containing vaccine, whenever given, boosts anti-mumps antibody levels.",
            "startOffset": 12991
        }
    ],
    "bib_entries": {
        "b0005": null,
        "b0010": null,
        "b0015": null,
        "b0020": {
            "authors": [
                {
                    "first": "Alya",
                    "initial": "A.",
                    "last": "Dabbagh"
                },
                {
                    "first": "Minal K.",
                    "initial": "M.K.",
                    "last": "Patel"
                },
                {
                    "first": "Laure",
                    "initial": "L.",
                    "last": "Dumolard"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Gacic-Dobo"
                },
                {
                    "first": "Mick N.",
                    "initial": "M.N.",
                    "last": "Mulders"
                },
                {
                    "first": "Jean Marie",
                    "initial": "J.M.",
                    "last": "Okwo-Bele"
                },
                {
                    "first": "Katrina",
                    "initial": "K.",
                    "last": "Kretsinger"
                },
                {
                    "first": "Mark J.",
                    "initial": "M.J.",
                    "last": "Papania"
                },
                {
                    "first": "Paul A.",
                    "initial": "P.A.",
                    "last": "Rota"
                },
                {
                    "first": "James L.",
                    "initial": "J.L.",
                    "last": "Goodson"
                }
            ],
            "doi": "10.15585/mmwr.mm6642a6",
            "firstpage": "1148",
            "issn": "01492195",
            "lastpage": "1153",
            "pmid": "29073125",
            "pub_year": 2017,
            "title": "Progress toward regional measles elimination- worldwide, 2000-2016",
            "volume": "66"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Justin P.",
                    "initial": "J.P.",
                    "last": "Albertson"
                },
                {
                    "first": "Whitney J.",
                    "initial": "W.J.",
                    "last": "Clegg"
                },
                {
                    "first": "Heather D.",
                    "initial": "H.D.",
                    "last": "Reid"
                },
                {
                    "first": "Benjamin S.",
                    "initial": "B.S.",
                    "last": "Arbise"
                },
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "Pryde"
                },
                {
                    "first": "Awais",
                    "initial": "A.",
                    "last": "Vaid"
                },
                {
                    "first": "Rachella",
                    "initial": "R.",
                    "last": "Thompson-Brown"
                },
                {
                    "first": "Fredrick",
                    "initial": "F.",
                    "last": "Echols"
                }
            ],
            "doi": "10.15585/mmwr.mm6529a2",
            "firstpage": "731",
            "issn": "01492195",
            "lastpage": "734",
            "pmid": "27467572",
            "pub_year": 2016,
            "title": "Mumps outbreak at a university and recommendation for a third dose of measles-mumps-rubella vaccine \u2014 Illinois, 2015-2016",
            "volume": "65"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Albert E.",
                    "initial": "A.E.",
                    "last": "Barskey"
                },
                {
                    "first": "John W.",
                    "initial": "J.W.",
                    "last": "Glasser"
                },
                {
                    "first": "Charles W.",
                    "initial": "C.W.",
                    "last": "LeBaron"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.06.109",
            "firstpage": "6186",
            "issn": "0264410X",
            "lastpage": "6195",
            "pmid": "19815120",
            "pub_year": 2009,
            "title": "Mumps resurgences in the United States: A historical perspective on unexpected elements",
            "volume": "27"
        },
        "b0035": null,
        "b0040": null,
        "b0045": null,
        "b0050": {
            "authors": [
                {
                    "first": "R. M.",
                    "initial": "R.M.",
                    "last": "Anderson"
                },
                {
                    "first": "R. M.",
                    "initial": "R.M.",
                    "last": "May"
                }
            ],
            "doi": "10.1016/0140-6736(90)90420-A",
            "firstpage": "641",
            "issn": "01406736",
            "lastpage": "645",
            "pmid": "1969023",
            "pub_year": 1990,
            "title": "Immunisation and herd immunity",
            "volume": "335"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Gustavo H.",
                    "initial": "G.H.",
                    "last": "Dayan"
                },
                {
                    "first": "M. Patricia",
                    "initial": "M.P.",
                    "last": "Quinlisk"
                },
                {
                    "first": "Amy A.",
                    "initial": "A.A.",
                    "last": "Parker"
                },
                {
                    "first": "Albert E.",
                    "initial": "A.E.",
                    "last": "Barskey"
                },
                {
                    "first": "Meghan L.",
                    "initial": "M.L.",
                    "last": "Harris"
                },
                {
                    "first": "Jennifer M.Hill",
                    "initial": "J.M.H.",
                    "last": "Schwartz"
                },
                {
                    "first": "Kae",
                    "initial": "K.",
                    "last": "Hunt"
                },
                {
                    "first": "Carol G.",
                    "initial": "C.G.",
                    "last": "Finley"
                },
                {
                    "first": "Dennis P.",
                    "initial": "D.P.",
                    "last": "Leschinsky"
                },
                {
                    "first": "Anne L.",
                    "initial": "A.L.",
                    "last": "O'Keefe"
                },
                {
                    "first": "Joshua",
                    "initial": "J.",
                    "last": "Clayton"
                },
                {
                    "first": "Lon K.",
                    "initial": "L.K.",
                    "last": "Kightlinger"
                },
                {
                    "first": "Eden G.",
                    "initial": "E.G.",
                    "last": "Dietle"
                },
                {
                    "first": "Jeffrey",
                    "initial": "J.",
                    "last": "Berg"
                },
                {
                    "first": "Cynthia L.",
                    "initial": "C.L.",
                    "last": "Kenyon"
                },
                {
                    "first": "Susan T.",
                    "initial": "S.T.",
                    "last": "Goldstein"
                },
                {
                    "first": "Shannon K.",
                    "initial": "S.K.",
                    "last": "Stokley"
                },
                {
                    "first": "Susan B.",
                    "initial": "S.B.",
                    "last": "Redd"
                },
                {
                    "first": "Paul A.",
                    "initial": "P.A.",
                    "last": "Rota"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Rota"
                },
                {
                    "first": "Daoling",
                    "initial": "D.",
                    "last": "Bi"
                },
                {
                    "first": "Sandra W.",
                    "initial": "S.W.",
                    "last": "Roush"
                },
                {
                    "first": "Carolyn B.",
                    "initial": "C.B.",
                    "last": "Bridges"
                },
                {
                    "first": "Tammy A.",
                    "initial": "T.A.",
                    "last": "Santibanez"
                },
                {
                    "first": "Umesh",
                    "initial": "U.",
                    "last": "Parashar"
                },
                {
                    "first": "William J.",
                    "initial": "W.J.",
                    "last": "Bellini"
                },
                {
                    "first": "Jane F.",
                    "initial": "J.F.",
                    "last": "Seward"
                }
            ],
            "doi": "10.1056/NEJMoa0706589",
            "firstpage": "1580",
            "issn": "00284793",
            "lastpage": "1589",
            "pmid": "18403766",
            "pub_year": 2008,
            "title": "Recent resurgence of mumps in the United States",
            "volume": "358"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Joseph A.",
                    "initial": "J.A.",
                    "last": "Lewnard"
                },
                {
                    "first": "Yonatan H.",
                    "initial": "Y.H.",
                    "last": "Grad"
                }
            ],
            "doi": "10.1126/scitranslmed.aao5945",
            "issn": "19466234",
            "pmid": "29563321",
            "pub_year": 2018,
            "title": "Vaccine waning and mumps re-emergence in the United States",
            "volume": "10"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Mona",
                    "initial": "M.",
                    "last": "Marin"
                },
                {
                    "first": "Mariel",
                    "initial": "M.",
                    "last": "Marlow"
                },
                {
                    "first": "Kelly L.",
                    "initial": "K.L.",
                    "last": "Moore"
                },
                {
                    "first": "Manisha",
                    "initial": "M.",
                    "last": "Patel"
                }
            ],
            "doi": "10.15585/mmwr.mm6701a7",
            "firstpage": "33",
            "issn": "01492195",
            "lastpage": "38",
            "pmid": "29324728",
            "pub_year": 2018,
            "title": "Recommendation of the advisory committee on immunization practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak",
            "volume": "67"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Irja",
                    "initial": "I.",
                    "last": "Davidkin"
                },
                {
                    "first": "Sari",
                    "initial": "S.",
                    "last": "Jokinen"
                },
                {
                    "first": "Mia",
                    "initial": "M.",
                    "last": "Broman"
                },
                {
                    "first": "Pauli",
                    "initial": "P.",
                    "last": "Leinikki"
                },
                {
                    "first": "Heikki",
                    "initial": "H.",
                    "last": "Peltola"
                }
            ],
            "doi": "10.1086/528993",
            "firstpage": "950",
            "issn": "00221899",
            "lastpage": "956",
            "pmid": "18419470",
            "pub_year": 2008,
            "title": "Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up",
            "volume": "197"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Ouzama",
                    "initial": "O.",
                    "last": "Henry"
                },
                {
                    "first": "Jerzy",
                    "initial": "J.",
                    "last": "Brzostek"
                },
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Czajka"
                },
                {
                    "first": "Giedra",
                    "initial": "G.",
                    "last": "Leviniene"
                },
                {
                    "first": "Olga",
                    "initial": "O.",
                    "last": "Reshetko"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Gasparini"
                },
                {
                    "first": "Petr",
                    "initial": "P.",
                    "last": "Pazdiora"
                },
                {
                    "first": "Doina",
                    "initial": "D.",
                    "last": "Plesca"
                },
                {
                    "first": "Maria Giuseppina",
                    "initial": "M.G.",
                    "last": "Desole"
                },
                {
                    "first": "Rimantas",
                    "initial": "R.",
                    "last": "Kevalas"
                },
                {
                    "first": "Giovanni",
                    "initial": "G.",
                    "last": "Gabutti"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Povey"
                },
                {
                    "first": "Bruce",
                    "initial": "B.",
                    "last": "Innis"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.11.081",
            "firstpage": "381",
            "issn": "0264410X",
            "lastpage": "387",
            "pmid": "29224964",
            "pub_year": 2018,
            "title": "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life",
            "volume": "36"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Povey"
                },
                {
                    "first": "Ouzama",
                    "initial": "O.",
                    "last": "Henry"
                },
                {
                    "first": "Marianne A.",
                    "initial": "M.A.",
                    "last": "Riise Bergsaker"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Esposito"
                },
                {
                    "first": "Carl Erik",
                    "initial": "C.E.",
                    "last": "Flodmark"
                },
                {
                    "first": "Leif",
                    "initial": "L.",
                    "last": "Gothefors"
                },
                {
                    "first": "Sorin",
                    "initial": "S.",
                    "last": "Man"
                },
                {
                    "first": "Sven Arne",
                    "initial": "S.A.",
                    "last": "Silfverdal"
                },
                {
                    "first": "M\u00e1ria",
                    "initial": "M.",
                    "last": "\u0160tefkovi\u010dov\u00e1"
                },
                {
                    "first": "Vytautas",
                    "initial": "V.",
                    "last": "Usonis"
                },
                {
                    "first": "Jacek",
                    "initial": "J.",
                    "last": "Wysocki"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Gillard"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                }
            ],
            "doi": "10.1016/S1473-3099(18)30716-3",
            "firstpage": "287",
            "issn": "14733099",
            "lastpage": "297",
            "pmid": "30765242",
            "pub_year": 2019,
            "title": "Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial",
            "volume": "19"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Marianne Riise",
                    "initial": "M.R.",
                    "last": "Bergsaker"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Esposito"
                },
                {
                    "first": "Leif",
                    "initial": "L.",
                    "last": "Gothefors"
                },
                {
                    "first": "Sorin",
                    "initial": "S.",
                    "last": "Man"
                },
                {
                    "first": "Nadezhda",
                    "initial": "N.",
                    "last": "Snegova"
                },
                {
                    "first": "M\u00e1ria",
                    "initial": "M.",
                    "last": "\u0160tefkovi\u010dova"
                },
                {
                    "first": "Vytautas",
                    "initial": "V.",
                    "last": "Usonis"
                },
                {
                    "first": "Jacek",
                    "initial": "J.",
                    "last": "Wysocki"
                },
                {
                    "first": "Martine",
                    "initial": "M.",
                    "last": "Douha"
                },
                {
                    "first": "Ventzislav",
                    "initial": "V.",
                    "last": "Vassilev"
                },
                {
                    "first": "Ouzama",
                    "initial": "O.",
                    "last": "Nicholson"
                },
                {
                    "first": "Bruce L.",
                    "initial": "B.L.",
                    "last": "Innis"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Willems"
                }
            ],
            "doi": "10.1016/S0140-6736(12)61461-5",
            "firstpage": "1313",
            "issn": "01406736",
            "lastpage": "1324",
            "pmid": "24485548",
            "pub_year": 2014,
            "title": "Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: A multicentre, observer-blind, randomised, controlled trial",
            "volume": "383"
        },
        "b0090": null,
        "b0095": null,
        "b0100": null,
        "b0105": {
            "authors": [
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Czajka"
                },
                {
                    "first": "Volker",
                    "initial": "V.",
                    "last": "Schuster"
                },
                {
                    "first": "Fred",
                    "initial": "F.",
                    "last": "Zepp"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Esposito"
                },
                {
                    "first": "Martine",
                    "initial": "M.",
                    "last": "Douha"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Willems"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.07.076",
            "firstpage": "6504",
            "issn": "0264410X",
            "lastpage": "6511",
            "pmid": "19665608",
            "pub_year": 2009,
            "title": "A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra\u2122): Immunogenicity and safety profile",
            "volume": "27"
        },
        "b0110": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Carazo Perez"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Bureau"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "De Serres"
                }
            ],
            "doi": "10.1017/S0950268818001474",
            "firstpage": "1584",
            "issn": "09502688",
            "lastpage": "1592",
            "pmid": "29886856",
            "pub_year": 2018,
            "title": "Post-immunisation fever and the antibody response to measles-containing vaccines",
            "volume": "146"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Sabine",
                    "initial": "S.",
                    "last": "Vygen"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Fischer"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Meurice"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Mounchetrou Njoya"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Gregoris"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Ndiaye"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Ghenassia"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Poujol"
                },
                {
                    "first": "J. P.",
                    "initial": "J.P.",
                    "last": "Stahl"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Antona"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Le Strat"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Levy-Bruhl"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Rolland"
                }
            ],
            "doi": "10.2807/1560-7917.ES.2016.21.10.30156",
            "issn": "1025496X",
            "pmid": "26987576",
            "pub_year": 2016,
            "title": "Waning immunity against mumps in vaccinated young adults, France 2013",
            "volume": "21"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Dalila",
                    "initial": "D.",
                    "last": "Hamami"
                },
                {
                    "first": "Ross",
                    "initial": "R.",
                    "last": "Cameron"
                },
                {
                    "first": "Kevin G.",
                    "initial": "K.G.",
                    "last": "Pollock"
                },
                {
                    "first": "Carron",
                    "initial": "C.",
                    "last": "Shankland"
                }
            ],
            "doi": "10.3389/fphys.2017.00233",
            "issn": "1664042X",
            "pub_year": 2017,
            "title": "Waning immunity is associated with periodic large outbreaks of mumps: A mathematical modeling study of scottish data",
            "volume": "8"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Emma E.",
                    "initial": "E.E.",
                    "last": "Seagle"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Bednarczyk"
                },
                {
                    "first": "Tenisha",
                    "initial": "T.",
                    "last": "Hill"
                },
                {
                    "first": "Amy Parker",
                    "initial": "A.P.",
                    "last": "Fiebelkorn"
                },
                {
                    "first": "Carole J.",
                    "initial": "C.J.",
                    "last": "Hickman"
                },
                {
                    "first": "Joseph P.",
                    "initial": "J.P.",
                    "last": "Icenogle"
                },
                {
                    "first": "Edward A.",
                    "initial": "E.A.",
                    "last": "Belongia"
                },
                {
                    "first": "Huong Q.",
                    "initial": "H.Q.",
                    "last": "McLean"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.12.075",
            "firstpage": "818",
            "issn": "0264410X",
            "lastpage": "826",
            "pmid": "29317117",
            "pub_year": 2018,
            "title": "Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine",
            "volume": "36"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Chin Yun",
                    "initial": "C.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Ren Bin",
                    "initial": "R.B.",
                    "last": "Tang"
                },
                {
                    "first": "Fu Yuan",
                    "initial": "F.Y.",
                    "last": "Huang"
                },
                {
                    "first": "Haiwen",
                    "initial": "H.",
                    "last": "Tang"
                },
                {
                    "first": "Li Min",
                    "initial": "L.M.",
                    "last": "Huang"
                },
                {
                    "first": "Hans L.",
                    "initial": "H.L.",
                    "last": "Bock"
                }
            ],
            "doi": "10.1016/S1201-9712(02)90112-8",
            "firstpage": "202",
            "issn": "12019712",
            "lastpage": "209",
            "pmid": "12718836",
            "pub_year": 2002,
            "title": "A new measles mumps rubella (MMR) vaccine: A randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children",
            "volume": "6"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Volker",
                    "initial": "V.",
                    "last": "Schuster"
                },
                {
                    "first": "Walter",
                    "initial": "W.",
                    "last": "Otto"
                },
                {
                    "first": "Lothar",
                    "initial": "L.",
                    "last": "Maurer"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Tcherepnine"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Pfletschinger"
                },
                {
                    "first": "Klaus",
                    "initial": "K.",
                    "last": "Kindler"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Soemantri"
                },
                {
                    "first": "Uta",
                    "initial": "U.",
                    "last": "Walther"
                },
                {
                    "first": "Ute",
                    "initial": "U.",
                    "last": "MacHoldt"
                },
                {
                    "first": "Martine",
                    "initial": "M.",
                    "last": "Douha"
                },
                {
                    "first": "Patrice",
                    "initial": "P.",
                    "last": "Pierson"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Willems"
                }
            ],
            "doi": "10.1097/INF.0b013e318170bb22",
            "firstpage": "724",
            "issn": "08913668",
            "lastpage": "730",
            "pmid": "18600190",
            "pub_year": 2008,
            "title": "Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life",
            "volume": "27"
        },
        "b0140": null,
        "b0145": {
            "authors": [
                {
                    "first": "Stanley A.",
                    "initial": "S.A.",
                    "last": "Plotkin"
                }
            ],
            "doi": "10.1128/CVI.00131-10",
            "firstpage": "1055",
            "issn": "15566811",
            "lastpage": "1065",
            "pmid": "20463105",
            "pub_year": 2010,
            "title": "Correlates of protection induced by vaccination",
            "volume": "17"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Remon",
                    "initial": "R.",
                    "last": "Abu-Elyazeed"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Jennings"
                },
                {
                    "first": "Randall",
                    "initial": "R.",
                    "last": "Severance"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Noss"
                },
                {
                    "first": "Adrian",
                    "initial": "A.",
                    "last": "Caplanusi"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Povey"
                },
                {
                    "first": "Ouzama",
                    "initial": "O.",
                    "last": "Henry"
                }
            ],
            "doi": "10.1080/21645515.2018.1489186",
            "firstpage": "2624",
            "issn": "21645515",
            "lastpage": "2631",
            "pmid": "29902133",
            "pub_year": 2018,
            "title": "Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7\u00a0years of age or older: A phase III, randomized study",
            "volume": "14"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Cristina V.",
                    "initial": "C.V.",
                    "last": "Cardemil"
                },
                {
                    "first": "Rebecca M.",
                    "initial": "R.M.",
                    "last": "Dahl"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "James"
                },
                {
                    "first": "Kathleen",
                    "initial": "K.",
                    "last": "Wannemuehler"
                },
                {
                    "first": "Howard E.",
                    "initial": "H.E.",
                    "last": "Gary"
                },
                {
                    "first": "Minesh",
                    "initial": "M.",
                    "last": "Shah"
                },
                {
                    "first": "Mona",
                    "initial": "M.",
                    "last": "Marin"
                },
                {
                    "first": "Jacob",
                    "initial": "J.",
                    "last": "Riley"
                },
                {
                    "first": "Daniel R.",
                    "initial": "D.R.",
                    "last": "Feikin"
                },
                {
                    "first": "Manisha",
                    "initial": "M.",
                    "last": "Patel"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Quinlisk"
                }
            ],
            "doi": "10.1056/NEJMoa1703309",
            "firstpage": "947",
            "issn": "00284793",
            "lastpage": "956",
            "pmid": "28877026",
            "pub_year": 2017,
            "title": "Effectiveness of a third dose of MMR vaccine for mumps outbreak control",
            "volume": "377"
        },
        "b0160": {
            "authors": [
                {
                    "first": "George E.",
                    "initial": "G.E.",
                    "last": "Nelson"
                },
                {
                    "first": "Annette",
                    "initial": "A.",
                    "last": "Aguon"
                },
                {
                    "first": "Engracia",
                    "initial": "E.",
                    "last": "Valencia"
                },
                {
                    "first": "Rita",
                    "initial": "R.",
                    "last": "Oliva"
                },
                {
                    "first": "Michele Leon",
                    "initial": "M.L.",
                    "last": "Guerrero"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Reyes"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Lizama"
                },
                {
                    "first": "Daryl",
                    "initial": "D.",
                    "last": "Diras"
                },
                {
                    "first": "Annakutty",
                    "initial": "A.",
                    "last": "Mathew"
                },
                {
                    "first": "Moryne Nicole",
                    "initial": "M.N.",
                    "last": "Monforte"
                },
                {
                    "first": "Tai Ho",
                    "initial": "T.H.",
                    "last": "Chen"
                },
                {
                    "first": "Abdirahman",
                    "initial": "A.",
                    "last": "Mahamud"
                },
                {
                    "first": "Preeta K.",
                    "initial": "P.K.",
                    "last": "Kutty"
                },
                {
                    "first": "Carole",
                    "initial": "C.",
                    "last": "Hickman"
                },
                {
                    "first": "William J.",
                    "initial": "W.J.",
                    "last": "Bellini"
                },
                {
                    "first": "Jane E.",
                    "initial": "J.E.",
                    "last": "Seward"
                },
                {
                    "first": "Kathleen",
                    "initial": "K.",
                    "last": "Gallagher"
                },
                {
                    "first": "Amy Parker",
                    "initial": "A.P.",
                    "last": "Fiebelkorn"
                }
            ],
            "doi": "10.1097/INF.0b013e318279f593",
            "firstpage": "374",
            "issn": "08913668",
            "lastpage": "380",
            "pmid": "23099425",
            "pub_year": 2013,
            "title": "Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control - Guam 2009 to 2010",
            "volume": "32"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Ikechukwu U.",
                    "initial": "I.U.",
                    "last": "Ogbuanu"
                },
                {
                    "first": "Preeta K.",
                    "initial": "P.K.",
                    "last": "Kutty"
                },
                {
                    "first": "Jean M.",
                    "initial": "J.M.",
                    "last": "Hudson"
                },
                {
                    "first": "Debra",
                    "initial": "D.",
                    "last": "Blog"
                },
                {
                    "first": "Glen R.",
                    "initial": "G.R.",
                    "last": "Abedi"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Goodell"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Lawler"
                },
                {
                    "first": "Huong Q.",
                    "initial": "H.Q.",
                    "last": "McLean"
                },
                {
                    "first": "Lynn",
                    "initial": "L.",
                    "last": "Pollock"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Rausch-Phung"
                },
                {
                    "first": "Cynthia",
                    "initial": "C.",
                    "last": "Schulte"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Valure"
                },
                {
                    "first": "Gregory L.",
                    "initial": "G.L.",
                    "last": "Armstrong"
                },
                {
                    "first": "Kathleen",
                    "initial": "K.",
                    "last": "Gallagher"
                }
            ],
            "doi": "10.1542/peds.2012-0177",
            "firstpage": "e1567",
            "issn": "00314005",
            "lastpage": "e1574",
            "pmid": "23129075",
            "pub_year": 2012,
            "title": "Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak",
            "volume": "130"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Neelam",
                    "initial": "N.",
                    "last": "Dhiman"
                },
                {
                    "first": "Inna G.",
                    "initial": "I.G.",
                    "last": "Ovsyannikova"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Jacobson"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Vierkant"
                },
                {
                    "first": "V. Shane",
                    "initial": "V.S.",
                    "last": "Pankratz"
                },
                {
                    "first": "Steven J.",
                    "initial": "S.J.",
                    "last": "Jacobsen"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Poland"
                }
            ],
            "doi": "10.1016/j.clim.2004.12.010",
            "firstpage": "154",
            "issn": "15216616",
            "lastpage": "161",
            "pmid": "15885638",
            "pub_year": 2005,
            "title": "Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children",
            "volume": "115"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "Vandermeulen"
                },
                {
                    "first": "Fr\u00e9d\u00e9ric",
                    "initial": "F.",
                    "last": "Clement"
                },
                {
                    "first": "Mathieu",
                    "initial": "M.",
                    "last": "Roelants"
                },
                {
                    "first": "Pierre Van",
                    "initial": "P.V.",
                    "last": "Damme"
                },
                {
                    "first": "Karel",
                    "initial": "K.",
                    "last": "Hoppenbrouwers"
                },
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                }
            ],
            "doi": "10.1086/598482",
            "firstpage": "1457",
            "issn": "00221899",
            "lastpage": "1460",
            "pmid": "19320590",
            "pub_year": 2009,
            "title": "Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination",
            "volume": "199"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Amy Parker",
                    "initial": "A.P.",
                    "last": "Fiebelkorn"
                },
                {
                    "first": "Laura A.",
                    "initial": "L.A.",
                    "last": "Coleman"
                },
                {
                    "first": "Edward A.",
                    "initial": "E.A.",
                    "last": "Belongia"
                },
                {
                    "first": "Sandra K.",
                    "initial": "S.K.",
                    "last": "Freeman"
                },
                {
                    "first": "Daphne",
                    "initial": "D.",
                    "last": "York"
                },
                {
                    "first": "Daoling",
                    "initial": "D.",
                    "last": "Bi"
                },
                {
                    "first": "Cheryl",
                    "initial": "C.",
                    "last": "Zhang"
                },
                {
                    "first": "Laurie",
                    "initial": "L.",
                    "last": "Ngo"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Rubin"
                }
            ],
            "doi": "10.1093/ofid/ofu094",
            "issn": "23288957",
            "pub_year": 2014,
            "title": "Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine",
            "volume": "1"
        },
        "b0185": null,
        "b0190": {
            "authors": [
                {
                    "first": "Iana H.",
                    "initial": "I.H.",
                    "last": "Haralambieva"
                },
                {
                    "first": "Inna G.",
                    "initial": "I.G.",
                    "last": "Ovsyannikova"
                },
                {
                    "first": "Megan",
                    "initial": "M.",
                    "last": "O'Byrne"
                },
                {
                    "first": "V. Shane",
                    "initial": "V.S.",
                    "last": "Pankratz"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Jacobson"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Poland"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.04.037",
            "firstpage": "4485",
            "issn": "0264410X",
            "lastpage": "4491",
            "pmid": "21539880",
            "pub_year": 2011,
            "title": "A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine",
            "volume": "29"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Iana H.",
                    "initial": "I.H.",
                    "last": "Haralambieva"
                },
                {
                    "first": "Hannah M.",
                    "initial": "H.M.",
                    "last": "Salk"
                },
                {
                    "first": "Nathaniel D.",
                    "initial": "N.D.",
                    "last": "Lambert"
                },
                {
                    "first": "Inna G.",
                    "initial": "I.G.",
                    "last": "Ovsyannikova"
                },
                {
                    "first": "Richard B.",
                    "initial": "R.B.",
                    "last": "Kennedy"
                },
                {
                    "first": "Nathaniel D.",
                    "initial": "N.D.",
                    "last": "Warner"
                },
                {
                    "first": "V. Shane",
                    "initial": "V.S.",
                    "last": "Pankratz"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Poland"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.01.090",
            "firstpage": "1946",
            "issn": "0264410X",
            "lastpage": "1953",
            "pmid": "24530932",
            "pub_year": 2014,
            "title": "Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts",
            "volume": "32"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Bracha",
                    "initial": "B.",
                    "last": "Rager-Zisman"
                },
                {
                    "first": "Elina",
                    "initial": "E.",
                    "last": "Bazarsky"
                },
                {
                    "first": "Agneta",
                    "initial": "A.",
                    "last": "Skibin"
                },
                {
                    "first": "Guy",
                    "initial": "G.",
                    "last": "Tam"
                },
                {
                    "first": "Shlomo",
                    "initial": "S.",
                    "last": "Chamney"
                },
                {
                    "first": "Ilana",
                    "initial": "I.",
                    "last": "Belmaker"
                },
                {
                    "first": "Iris",
                    "initial": "I.",
                    "last": "Shai"
                },
                {
                    "first": "Ella",
                    "initial": "E.",
                    "last": "Kordysh"
                },
                {
                    "first": "Diane E.",
                    "initial": "D.E.",
                    "last": "Griffin"
                }
            ],
            "doi": "10.1128/CDLI.11.5.913-918.2004",
            "firstpage": "913",
            "issn": "1071412X",
            "lastpage": "918",
            "pmid": "15358652",
            "pub_year": 2004,
            "title": "Differential immune responses to primary measles-mumps-rubella vaccination in Israeli children",
            "volume": "11"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Benjamin J.",
                    "initial": "B.J.",
                    "last": "Umlauf"
                },
                {
                    "first": "Iana H.",
                    "initial": "I.H.",
                    "last": "Haralambieva"
                },
                {
                    "first": "Inna G.",
                    "initial": "I.G.",
                    "last": "Ovsyannikova"
                },
                {
                    "first": "Richard B.",
                    "initial": "R.B.",
                    "last": "Kennedy"
                },
                {
                    "first": "V. Shane",
                    "initial": "V.S.",
                    "last": "Pankratz"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Jacobson"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Poland"
                }
            ],
            "doi": "10.1089/vim.2011.0051",
            "firstpage": "29",
            "issn": "08828245",
            "lastpage": "36",
            "pmid": "22239234",
            "pub_year": 2012,
            "title": "Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination",
            "volume": "25"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Emily A.",
                    "initial": "E.A.",
                    "last": "Voigt"
                },
                {
                    "first": "Inna G.",
                    "initial": "I.G.",
                    "last": "Ovsyannikova"
                },
                {
                    "first": "Iana H.",
                    "initial": "I.H.",
                    "last": "Haralambieva"
                },
                {
                    "first": "Richard B.",
                    "initial": "R.B.",
                    "last": "Kennedy"
                },
                {
                    "first": "Beth R.",
                    "initial": "B.R.",
                    "last": "Larrabee"
                },
                {
                    "first": "Daniel J.",
                    "initial": "D.J.",
                    "last": "Schaid"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Poland"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.08.060",
            "firstpage": "4913",
            "issn": "0264410X",
            "lastpage": "4919",
            "pmid": "27591105",
            "pub_year": 2016,
            "title": "Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination",
            "volume": "34"
        }
    },
    "body_text": [
        {
            "endOffset": 20298,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Sera were stored and transported at \u221220 \u00b0C until assayed using standardized and validated procedures at a central laboratory (GSK Biologicals Global Vaccine Clinical Laboratory, Rixensart, Belgium for samples until Year 6; assays transferred to N\u00e9omed-Labs, Laval, Quebec, Canada for Year 8 and Year 10 samples).",
            "startOffset": 19986,
            "title": "Study vaccines and procedures"
        },
        {
            "endOffset": 32753,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 32638,
                    "startOffset": 32628
                },
                "b0130": {
                    "endOffset": 32638,
                    "startOffset": 32628
                },
                "b0135": {
                    "endOffset": 32638,
                    "startOffset": 32628
                },
                "b0140": {
                    "endOffset": 32752,
                    "startOffset": 32748
                }
            },
            "secId": "s0055",
            "sentence": "This observation agrees with what has been reported previously [21,26,27], and represents one of the reasons for recommending a 2-dose vaccination schedule of MMR-containing vaccines [28].",
            "startOffset": 32565,
            "title": "Discussion"
        },
        {
            "endOffset": 35094,
            "parents": [],
            "refoffsets": {
                "b0150": {
                    "endOffset": 35093,
                    "startOffset": 35089
                }
            },
            "secId": "s0055",
            "sentence": "In agreement with this observation, Priorix has recently been shown to elicit high immune responses\u2014which were not inferior to a comparator vaccine\u2014when given to individuals \u2265 7 years old previously primed with a MMR-containing vaccine [30].",
            "startOffset": 34853,
            "title": "Discussion"
        },
        {
            "endOffset": 39391,
            "parents": [],
            "secId": "s0055",
            "sentence": "As expected in long follow-up studies, such as the present study, sample sizes may be low at the end of the follow-up and results at late time points should be considered with caution.",
            "startOffset": 39207,
            "title": "Discussion"
        },
        {
            "endOffset": 40070,
            "parents": [],
            "secId": "s0055",
            "sentence": "To partially account for that, and to understand the role of a second dose given later than in the other groups, a post-hoc analysis was conducted to investigate the persistence of antibodies in MMR+V children who received a (later) second dose of MMR-containing vaccine.",
            "startOffset": 39799,
            "title": "Discussion"
        },
        {
            "endOffset": 29537,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, children in the MMRV group (who received 2 doses of MMRV 42 days apart) showed the highest GMCs at all time points.",
            "startOffset": 29413,
            "title": "Discussion"
        },
        {
            "endOffset": 38203,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 38052,
                    "startOffset": 38045
                },
                "b0185": {
                    "endOffset": 38052,
                    "startOffset": 38045
                }
            },
            "secId": "s0055",
            "sentence": "The boosting of antibody levels observed in the present study and the catch-up effect in children who did not respond to a first dose support the use of additional doses of mumps-containing vaccines at later ages to increase anti-mumps antibody levels, at least transiently (see also [36,37]), and to promote seroresponse in case of response failure at previous doses, which in turn could lead to a higher individual and community protection.",
            "startOffset": 37761,
            "title": "Discussion"
        },
        {
            "endOffset": 29412,
            "parents": [],
            "secId": "s0055",
            "sentence": "The evolution of anti-measles antibody levels over time was similar among groups, regardless of whether 1 or 2 doses of MMR had been administered.",
            "startOffset": 29266,
            "title": "Discussion"
        },
        {
            "endOffset": 19781,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Children were randomized 3:3:1 to receive by subcutaneous injection in the deltoid region, respectively, one of the following vaccination regimens: (a) 2 doses of MMRV at Day 0 and Day 42 (MMRV group), (b) 1 dose of MMR at Day 0 and 1 dose of V at Day 42 (MMR+V group) or (c) 2 doses of MMR at Day 0 and Day 42 (MMR group).",
            "startOffset": 19458,
            "title": "Study vaccines and procedures"
        },
        {
            "endOffset": 26030,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "The seropositivity rates peaked at Day 84 in the groups who received a second dose of MMR-containing vaccine at Day 42: 97.8% seropositivity rate in the MMRV group and 100% in MMR group.",
            "startOffset": 25844,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 34852,
            "parents": [],
            "secId": "s0055",
            "sentence": "Seropositivity rates increased in parallel to the antibody level increases.",
            "startOffset": 34777,
            "title": "Discussion"
        },
        {
            "endOffset": 36399,
            "parents": [],
            "secId": "s0055",
            "sentence": "These multiple observations suggest that mumps vaccination is able to elicit a memory antibody response that can be recalled many years later.",
            "startOffset": 36257,
            "title": "Discussion"
        },
        {
            "endOffset": 40976,
            "parents": [],
            "secId": "s0055",
            "sentence": "As a conclusion, this study describes different profiles of long-term antibody persistence and boostability for each of the components of MMR-containing vaccines, depending also on the vaccine used and timing of doses.",
            "startOffset": 40758,
            "title": "Discussion"
        },
        {
            "endOffset": 31534,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 31533,
                    "startOffset": 31526
                },
                "b0120": {
                    "endOffset": 31533,
                    "startOffset": 31526
                }
            },
            "secId": "s0055",
            "sentence": "This observation is not consistent with recent reports demonstrating waning of immunity of mumps vaccines [23,24].",
            "startOffset": 31420,
            "title": "Discussion"
        },
        {
            "endOffset": 23766,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "All statistical analyses were descriptive only; no formal statistical hypotheses were formulated.",
            "startOffset": 23669,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 30477,
            "parents": [],
            "secId": "s0055",
            "sentence": "In the present study, not only do we observe these expected higher GMCs in the MMRV group during the most immediate post-vaccination period, but we also show that these persist well until Year 10 post-vaccination.",
            "startOffset": 30264,
            "title": "Discussion"
        },
        {
            "endOffset": 32246,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 32245,
                    "startOffset": 32241
                }
            },
            "secId": "s0055",
            "sentence": "Moreover, a very recent model based on a meta-analysis suggested that the average waning of immunity against mumps occurs 27 years (95% confidence interval: 16\u201351 years) post-vaccination [12].",
            "startOffset": 32054,
            "title": "Discussion"
        },
        {
            "endOffset": 28614,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "However, receipt of the second dose later in life transiently reduced the speed of the decline in anti-rubella antibody levels over time (Fig. 4F).",
            "startOffset": 28467,
            "title": "Anti-rubella persistence"
        },
        {
            "endOffset": 31419,
            "parents": [],
            "secId": "s0055",
            "sentence": "Anti-mumps antibody titers remained fairly stable over the 10-year period after both the 1-dose schedule (MMR+V group) and the 2-dose schedule (MMRV and MMR groups).",
            "startOffset": 31254,
            "title": "Discussion"
        },
        {
            "endOffset": 33877,
            "parents": [],
            "secId": "s0055",
            "sentence": "These children were part of the MMR+V group and thus, per protocol, were given only 1 dose of MMR.",
            "startOffset": 33779,
            "title": "Discussion"
        },
        {
            "endOffset": 27740,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Seropositivity rates for anti-rubella antibody remained high across study groups and sub-groups over time, with \u226596.6% of children being seropositive for anti-rubella antibodies at Year 10 (Fig. 3B).",
            "startOffset": 27541,
            "title": "Anti-rubella persistence"
        },
        {
            "endOffset": 32053,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 32001,
                    "startOffset": 31997
                }
            },
            "secId": "s0055",
            "sentence": "This might partially explain why the serological surveys are detecting waning over a long period of time and why only 11% of the waning could be explained by time in the model of Seagle et al. [25], which assumed a linear decline of antibody titers.",
            "startOffset": 31804,
            "title": "Discussion"
        },
        {
            "endOffset": 31668,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, none of these recent reports actually followed antibody titers in the same subjects over time, as done in the present study.",
            "startOffset": 31535,
            "title": "Discussion"
        },
        {
            "endOffset": 40434,
            "parents": [],
            "secId": "s0055",
            "sentence": "In any case, all the results from the present study are descriptive only and no statistical hypotheses were set a priori.",
            "startOffset": 40313,
            "title": "Discussion"
        },
        {
            "endOffset": 35572,
            "parents": [],
            "secId": "s0055",
            "sentence": "The anti-mumps antibody boost observed upon a second dose of MMR-containing vaccine after Year 4 is also in line with the recent use of this vaccine later in life in outbreak settings.",
            "startOffset": 35388,
            "title": "Discussion"
        },
        {
            "endOffset": 38352,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 38351,
                    "startOffset": 38347
                }
            },
            "secId": "s0055",
            "sentence": "Again, this is in line with the recent recommendation of a third dose of mumps-containing vaccine for individuals at risk in outbreak settings [13].",
            "startOffset": 38204,
            "title": "Discussion"
        },
        {
            "endOffset": 25843,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Seropositivity rates for anti-mumps antibody ranged from 86.6% to 100% across study groups during the entire study period; at Year 10 after vaccination, \u226590.0% of children were still seropositive for anti-mumps antibody (Fig. 3C).",
            "startOffset": 25613,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 32332,
            "parents": [],
            "secId": "s0055",
            "sentence": "Our study might therefore be not long enough to show actual waning of mumps serology.",
            "startOffset": 32247,
            "title": "Discussion"
        },
        {
            "endOffset": 40312,
            "parents": [],
            "secId": "s0055",
            "sentence": "Even though valuable results were obtained, the post-hoc analysis was restricted to a small number of subjects and did not account for the effect of potential natural infections, so the conclusions drawn from it should be taken with caution.",
            "startOffset": 40071,
            "title": "Discussion"
        },
        {
            "endOffset": 36662,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 36661,
                    "startOffset": 36654
                },
                "b0175": {
                    "endOffset": 36661,
                    "startOffset": 36654
                }
            },
            "secId": "s0055",
            "sentence": "This is in accordance with the long-term persistence of cellular mediated immunity shown for the mumps component of the MMR vaccine, which may have triggered the efficient and fast generation of anti-mumps antibodies after the second dose administration [34,35].",
            "startOffset": 36400,
            "title": "Discussion"
        },
        {
            "endOffset": 32880,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, seropositivity rates remained high.",
            "startOffset": 32836,
            "title": "Discussion"
        },
        {
            "endOffset": 40582,
            "parents": [],
            "secId": "s0055",
            "sentence": "The main strengths of this study are the large cohort considered, the long follow-up and the use of different MMR-containing vaccines and schedules.",
            "startOffset": 40434,
            "title": "Discussion"
        },
        {
            "endOffset": 22691,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "These participants (a total of 364 children) were divided in three sub-groups according to the time window when they received their second dose of MMR-containing vaccine: in Year 4\u20136 (sub-group MMR+V 4\u20136; N = 208), Year 6\u20138 (sub-group MMR+V 6\u20138; N = 73) or Year 8\u201310 (sub-group MMR+V 8\u201310; N = 83).",
            "startOffset": 22393,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 24366,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Demographic characteristics of the participants were balanced among the 3 groups (Table 1).",
            "startOffset": 24275,
            "title": "Study participants"
        },
        {
            "endOffset": 41224,
            "parents": [],
            "secId": "s0055",
            "sentence": "Importantly, we have shown that the responses obtained after receipt of 1 or 2 doses of MMR-containing vaccines remain well above the seropositivity thresholds up to 10 years post-vaccination, regardless of the vaccine given and the schedule used.",
            "startOffset": 40977,
            "title": "Discussion"
        },
        {
            "endOffset": 39616,
            "parents": [],
            "secId": "s0055",
            "sentence": "In our study, this is particularly remarkable for the MMR+V group, as all children in this group who received a second dose of a MMR-containing vaccine out of protocol were censored from the analysis after their second dose.",
            "startOffset": 39392,
            "title": "Discussion"
        },
        {
            "endOffset": 16563,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 16562,
                    "startOffset": 16553
                },
                "b0050": {
                    "endOffset": 16562,
                    "startOffset": 16553
                },
                "b0055": {
                    "endOffset": 16562,
                    "startOffset": 16553
                },
                "b0060": {
                    "endOffset": 16562,
                    "startOffset": 16553
                }
            },
            "secId": "s0005",
            "sentence": "The main hypothesized cause for mumps outbreaks is a combination of the following: a high density of population (such as college campuses) that concentrate more susceptible subjects, the waning of antibody titers, a lower effectiveness of mumps-containing vaccines compared to measles and rubella vaccines, and currently circulating strains for which cross-neutralization is less effective [6,10\u201312].",
            "startOffset": 16163,
            "title": "Introduction"
        },
        {
            "endOffset": 21802,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Evaluation of antibodies against measles, mumps and rubella at each time point was based on the adapted according-to-protocol (ATP) cohort for MMR persistence, i.e. considering only the serology results of children in the subset for MMR persistence who respected all the visit intervals up to and including the time point considered and who were seronegative prior to vaccination.",
            "startOffset": 21422,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 38393,
            "parents": [],
            "secId": "s0055",
            "sentence": "There are some limitations to this study.",
            "startOffset": 38352,
            "title": "Discussion"
        },
        {
            "endOffset": 25482,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "At Day 84, children who received only 1 dose of MMR vaccine (MMR+V group) reached anti-measles GMCs similar to those seen in children who received 2 doses (MMR group).",
            "startOffset": 25315,
            "title": "Anti-measles persistence"
        },
        {
            "endOffset": 17163,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 17162,
                    "startOffset": 17158
                }
            },
            "secId": "s0005",
            "sentence": "It has been shown that levels of anti-measles, -mumps, or -rubella antibodies decline over time, and this happens faster after vaccination than when immunity is naturally acquired [14].",
            "startOffset": 16978,
            "title": "Introduction"
        },
        {
            "endOffset": 22838,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Too few subjects in the MMR+V group received a second dose of MMR-containing vaccine before Year 4 to justify the creation of a separate subgroup.",
            "startOffset": 22692,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 24885,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "This second dose later in life did not have any impact on anti-measles seropositivity rate (Supplementary Fig. 2).",
            "startOffset": 24771,
            "title": "Anti-measles persistence"
        },
        {
            "endOffset": 17938,
            "parents": [],
            "secId": "s0005",
            "sentence": "A summary contextualizing the outcomes of this study is displayed in the Focus on the Patient Section (Fig. 1) for the convenience of health care professionals.",
            "startOffset": 17778,
            "title": "Introduction"
        },
        {
            "endOffset": 22392,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "However, serological data from participants in the MMR+V group who received a second dose of MMR-containing vaccine between Year 4 and the end of Year 10 (often in accordance with their country\u2019s specific vaccination schedule) were used in a post-hoc analysis to describe the persistence of antibodies when the second dose of MMR-containing vaccine was given later in life.",
            "startOffset": 22019,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 29266,
            "parents": [],
            "secId": "s0055",
            "sentence": "Levels of anti-mumps antibodies remained relatively stable over the 10-year follow-up, whereas GMCs for anti-measles and anti-rubella antibodies moderately declined from Day 84 onward.",
            "startOffset": 29082,
            "title": "Discussion"
        },
        {
            "endOffset": 29847,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 29846,
                    "startOffset": 29842
                }
            },
            "secId": "s0055",
            "sentence": "This is consistent with a previously published study where children who received 2 doses of MMRV showed anti-measles GMTs up to Day 84 post-vaccination that were 1.8-fold higher compared with children who received 2 doses of MMR 42 days apart with concomitant varicella vaccination at the first MMR dose [21].",
            "startOffset": 29538,
            "title": "Discussion"
        },
        {
            "endOffset": 33528,
            "parents": [],
            "secId": "s0055",
            "sentence": "The observation that anti-rubella antibody GMCs between Day 42 and Day 84 in the MMR+V group (1 dose) increased similarly to those in the MMRV and MMR groups (2 doses) could put into question the timing of immunogenicity assessment of the rubella component of the vaccines.",
            "startOffset": 33255,
            "title": "Discussion"
        },
        {
            "endOffset": 31067,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, this decline in seropositivity rates as of Year 4 was accompanied by a high variability (large 95% CIs), pointing to a potential confounding effect of a decrease in sample size at later timepoints.",
            "startOffset": 30861,
            "title": "Discussion"
        },
        {
            "endOffset": 15486,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 15485,
                    "startOffset": 15480
                },
                "b0010": {
                    "endOffset": 15485,
                    "startOffset": 15480
                },
                "b0015": {
                    "endOffset": 15485,
                    "startOffset": 15480
                },
                "b0020": {
                    "endOffset": 15485,
                    "startOffset": 15480
                }
            },
            "secId": "s0005",
            "sentence": "Implementation of universal routine vaccination programs with measles-, mumps- and/or rubella-containing vaccines has dramatically reduced the incidence of these diseases and their associated mortality and morbidity [1\u20134].",
            "startOffset": 15264,
            "title": "Introduction"
        },
        {
            "endOffset": 28466,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Children in sub-groups MMR+V 4\u20136, MMR+V 6\u20138 and MMR+V 8\u201310, who received their second dose of MMR-containing vaccine after Year 4, did not reach the same post-dose 2 anti-rubella antibody GMCs as children who received the second dose at Day 42 (Fig. 4C).",
            "startOffset": 28212,
            "title": "Anti-rubella persistence"
        },
        {
            "endOffset": 17489,
            "parents": [],
            "secId": "s0005",
            "sentence": "In this study, we administered 1 or 2 doses of MMR-containing vaccines to healthy children using different vaccines and schedules with or without concomitant varicella vaccination.",
            "startOffset": 17309,
            "title": "Introduction"
        },
        {
            "endOffset": 31254,
            "parents": [],
            "secId": "s0055",
            "sentence": "In any case, the percentage of subjects with anti-measles antibody concentrations above the seropositivity threshold remained higher than 93.3% at all timepoints and across study groups.",
            "startOffset": 31068,
            "title": "Discussion"
        },
        {
            "endOffset": 41346,
            "parents": [],
            "secId": "s0060",
            "sentence": "Priorix, Priorix-Tetra and Varilrix are trademarks owned by or licensed to the GSK group of companies.",
            "startOffset": 41244,
            "title": "Trademark statement"
        },
        {
            "endOffset": 16977,
            "parents": [],
            "secId": "s0005",
            "sentence": "Another crucial point for the success of MMR vaccination programs is the degree of long-lasting immunity and effectiveness of the vaccines.",
            "startOffset": 16838,
            "title": "Introduction"
        },
        {
            "endOffset": 26465,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "At the end of the follow-up, GMCs were 889 U/mL, 1054 U/mL and 913 U/mL in the MMRV, MMR+V and MMR groups respectively (Fig. 4C).",
            "startOffset": 26336,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 35388,
            "parents": [],
            "secId": "s0055",
            "sentence": "In our study, the increase in seropositivity rates after a (later) second dose reflects both children newly seroconverted (i.e., non-responders after dose 1) and children who responded to dose 1 but whose antibody levels waned below the seropositivity threshold before dose 2 (data not shown).",
            "startOffset": 35095,
            "title": "Discussion"
        },
        {
            "endOffset": 18991,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Independent ethics review committees or institutional review boards at each site approved the study protocol, a summary of which is available at www.gsk-clinicalstudyregister.com (study IDs 100388, 103494, 104105, 104106).",
            "startOffset": 18769,
            "title": "Study design and participants"
        },
        {
            "endOffset": 40758,
            "parents": [],
            "secId": "s0055",
            "sentence": "This provides a unique long-term descriptive comparison of measles, mumps and rubella immunogenicity across different vaccines and vaccination schedules over a 10-year period.",
            "startOffset": 40583,
            "title": "Discussion"
        },
        {
            "endOffset": 16838,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 16837,
                    "startOffset": 16833
                }
            },
            "secId": "s0005",
            "sentence": "To prevent mumps outbreaks, not only is the completion of the recommended measles-mumps-rubella (MMR) vaccination schedule crucial, but also a third dose of MMR vaccine has been recently recommended in the USA to help reduce the number of cases during a mumps outbreak [13].",
            "startOffset": 16564,
            "title": "Introduction"
        },
        {
            "endOffset": 24457,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "The mean age at enrollment was 14.6 months and 97.5% of participants were white/Caucasian.",
            "startOffset": 24367,
            "title": "Study participants"
        },
        {
            "endOffset": 28701,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Sub-group MMR+V 8\u201310 also showed a transient sustainment in antibody levels at Year 1.",
            "startOffset": 28615,
            "title": "Anti-rubella persistence"
        },
        {
            "endOffset": 38748,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 38747,
                    "startOffset": 38740
                },
                "b0195": {
                    "endOffset": 38747,
                    "startOffset": 38740
                },
                "b0200": {
                    "endOffset": 38747,
                    "startOffset": 38740
                },
                "b0205": {
                    "endOffset": 38747,
                    "startOffset": 38740
                },
                "b0210": {
                    "endOffset": 38747,
                    "startOffset": 38740
                }
            },
            "secId": "s0055",
            "sentence": "It has been reported that vaccine-induced measles and rubella immune responses are affected by ethnic differences, so the conclusions derived from this study on measles and rubella long-term immunogenicity might not necessarily be generalizable to children of all ethnicities [38\u201342].",
            "startOffset": 38464,
            "title": "Discussion"
        },
        {
            "endOffset": 18260,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 18259,
                    "startOffset": 18252
                },
                "b0080": {
                    "endOffset": 18259,
                    "startOffset": 18252
                },
                "b0085": {
                    "endOffset": 18259,
                    "startOffset": 18252
                }
            },
            "secId": "s0015",
            "sentence": "Details of the study design have been previously published [15\u201317].",
            "startOffset": 18193,
            "title": "Study design and participants"
        },
        {
            "endOffset": 37761,
            "parents": [],
            "secId": "s0055",
            "sentence": "This observation suggests that a catch-up dose of mumps-containing vaccine is important and elicits an efficient immune response in individuals with an incomplete vaccination schedule.",
            "startOffset": 37577,
            "title": "Discussion"
        },
        {
            "endOffset": 26335,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "From Day 84 to Year 10, the levels of anti-mumps antibody remained relatively stable over time in the MMRV, MMR+V and MMR groups.",
            "startOffset": 26206,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 23845,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Statistical analyses were performed using Statistical Analysis Software (SAS).",
            "startOffset": 23767,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 39121,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, we achieved a sample size as large as pre-specified in the study protocol, and participants showed balanced baseline characteristics among study groups.",
            "startOffset": 38960,
            "title": "Discussion"
        },
        {
            "endOffset": 15636,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 15635,
                    "startOffset": 15630
                },
                "b0030": {
                    "endOffset": 15635,
                    "startOffset": 15630
                }
            },
            "secId": "s0005",
            "sentence": "However, measles and mumps outbreaks still occur\u2014each of them for different reasons\u2014in regions where safe and effective vaccines are available [5,6].",
            "startOffset": 15487,
            "title": "Introduction"
        },
        {
            "endOffset": 21421,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The subset for MMR persistence was identified through the Internet randomization system and consisted of up to 200 subjects from each country (however, children in Greece and the Russian Federation did not contribute to data beyond Year 2).",
            "startOffset": 21181,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 31803,
            "parents": [],
            "secId": "s0055",
            "sentence": "One important observation is the rapid decline of antibody GMCs after the second dose down to levels similar to post-dose 1 (Fig. 4C).",
            "startOffset": 31669,
            "title": "Discussion"
        },
        {
            "endOffset": 33666,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 33665,
                    "startOffset": 33661
                }
            },
            "secId": "s0055",
            "sentence": "However, the waning of antibody titer and the fact that rubella has a correlate of protection is making this questioning irrelevant [29].",
            "startOffset": 33529,
            "title": "Discussion"
        },
        {
            "endOffset": 34402,
            "parents": [],
            "secId": "s0055",
            "sentence": "For anti-rubella antibodies, a second dose slowed down the antibody waning.",
            "startOffset": 34327,
            "title": "Discussion"
        },
        {
            "endOffset": 27857,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Anti-rubella antibody GMCs at Day 84 were similar across groups irrespective of the number of vaccine doses received.",
            "startOffset": 27740,
            "title": "Anti-rubella persistence"
        },
        {
            "endOffset": 19457,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 19456,
                    "startOffset": 19449
                },
                "b0095": {
                    "endOffset": 19456,
                    "startOffset": 19449
                },
                "b0100": {
                    "endOffset": 19456,
                    "startOffset": 19449
                }
            },
            "secId": "s0020",
            "sentence": "The composition of these vaccines has been previously described [18\u201320].",
            "startOffset": 19385,
            "title": "Study vaccines and procedures"
        },
        {
            "endOffset": 34210,
            "parents": [],
            "secId": "s0055",
            "sentence": "We performed a post-hoc analysis to evaluate the immune response of these children to the later second dose, and found different responses for each of the serologies tested.",
            "startOffset": 34037,
            "title": "Discussion"
        },
        {
            "endOffset": 20740,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Participants, parents/legally acceptable representatives (LARs), investigators and the personnel who assessed the study outcomes remained blinded to the intervention in all groups except for children (and their parents/LARs) of the MMR+V group in countries where the recommended national immunization program included a second dose of MMR vaccination at 4\u20138 years of age: Czech Republic, Italy, Lithuania, Romania, Russian Federation, Sweden.",
            "startOffset": 20298,
            "title": "Study vaccines and procedures"
        },
        {
            "endOffset": 20968,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Serum immunoglobulin G antibodies against measles, mumps and rubella viruses were measured using commercial enzyme-linked immunosorbent assay (ELISA) kits specific to each serology (Enzygnost, Siemens [previously Dade Behring]).",
            "startOffset": 20740,
            "title": "Study vaccines and procedures"
        },
        {
            "endOffset": 23992,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 23991,
                    "startOffset": 23987
                }
            },
            "secId": "s0035",
            "sentence": "A total of 5803 children aged 12\u201322 months were enrolled and vaccinated between 1 September 2005 and 10 May 2006 [17].",
            "startOffset": 23874,
            "title": "Study participants"
        },
        {
            "endOffset": 25066,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "In all groups, anti-measles antibody GMCs declined from Day 84 onwards (Fig. 4A).",
            "startOffset": 24985,
            "title": "Anti-measles persistence"
        },
        {
            "endOffset": 17309,
            "parents": [],
            "secId": "s0005",
            "sentence": "It is important to better understand vaccine-induced antibody persistence and how persistence patterns may influence the risk of vaccine failure.",
            "startOffset": 17164,
            "title": "Introduction"
        },
        {
            "endOffset": 24133,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Of these, 1887 were included in the subset for MMR persistence, from which 1647 were included in the adapted ATP cohort for MMR persistence.",
            "startOffset": 23993,
            "title": "Study participants"
        },
        {
            "endOffset": 34326,
            "parents": [],
            "secId": "s0055",
            "sentence": "For anti-measles antibodies, a second dose after Year 4 had an almost negligible effect on antibody concentrations.",
            "startOffset": 34211,
            "title": "Discussion"
        },
        {
            "endOffset": 39798,
            "parents": [],
            "secId": "s0055",
            "sentence": "This is especially noticeable after Year 6, and in consequence the seropositivity rates and GMC results for the MMR+V group after that time point should be interpreted with caution.",
            "startOffset": 39617,
            "title": "Discussion"
        },
        {
            "endOffset": 26995,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "This was observed regardless of when the second dose was given between Year 4 and Year 10.",
            "startOffset": 26905,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 33254,
            "parents": [],
            "secId": "s0055",
            "sentence": "The small increase in GMCs observed in the MMR+V group at Year 10 may be attributable to a bias due to the thinning out of the cohorts rather than a real change in anti-rubella antibodies, therefore data in the MMR+V group from Year 6 to Year 10 have to be considered cautiously due to the low number of children after censoring data of subjects who received a second dose.",
            "startOffset": 32881,
            "title": "Discussion"
        },
        {
            "endOffset": 41422,
            "parents": [],
            "secId": "s0060",
            "sentence": "Enzygnost is a trademark of Siemens (previously Dade Behring Marburg GmbH).",
            "startOffset": 41347,
            "title": "Trademark statement"
        },
        {
            "endOffset": 21180,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The immunogenicity of the measles, mumps and rubella components of the study vaccines was assessed in the subset for MMR persistence, which included 1887 participants over the 10 countries.",
            "startOffset": 20991,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 24626,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Seropositivity rates for anti-measles antibody remained high (\u226593.4%) throughout the ten years after vaccination across study groups (Fig. 3).",
            "startOffset": 24484,
            "title": "Anti-measles persistence"
        },
        {
            "endOffset": 18768,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was conducted in Czech Republic, Greece, Italy, Lithuania, Norway, Poland, Romania, Russian Federation, Slovakia and Sweden according to the Declaration of Helsinki and the Good Clinical Practice guidelines (NCT00226499).",
            "startOffset": 18537,
            "title": "Study design and participants"
        },
        {
            "endOffset": 23031,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Antibody geometric mean concentrations (GMCs) were calculated for each group (and sub-group) and time point by taking the anti-log of the mean of the log antibody concentrations for each assay.",
            "startOffset": 22838,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 24275,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Main reasons for exclusion were having essential serological data missing and being initially seropositive or of unknown serostatus (Fig. 2).",
            "startOffset": 24134,
            "title": "Study participants"
        },
        {
            "endOffset": 32835,
            "parents": [],
            "secId": "s0055",
            "sentence": "Anti-rubella antibody levels declined gradually over the 10-year follow-up period.",
            "startOffset": 32753,
            "title": "Discussion"
        },
        {
            "endOffset": 15801,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 15800,
                    "startOffset": 15797
                }
            },
            "secId": "s0005",
            "sentence": "For instance, only in the first half of 2018, over 41,000 children and adults were infected with measles in the World Health Organization (WHO) European region [7].",
            "startOffset": 15637,
            "title": "Introduction"
        },
        {
            "endOffset": 26904,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Children in the MMR+V group who received their second dose of MMR-containing vaccine later in life (sub-groups MMR+V 4\u20136, MMR+V 6\u20138 and MMR+V 8\u201310) reached similar post-dose 2 anti-mumps antibody GMCs as those observed in MMRV and MMR groups (Fig. 4C and D).",
            "startOffset": 26646,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 29081,
            "parents": [],
            "secId": "s0055",
            "sentence": "All groups showed high seropositivity rates 10 years post-vaccination, regardless of the MMR-containing vaccine regimen administered.",
            "startOffset": 28948,
            "title": "Discussion"
        },
        {
            "endOffset": 18537,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 18509,
                    "startOffset": 18502
                },
                "b0080": {
                    "endOffset": 18509,
                    "startOffset": 18502
                },
                "b0085": {
                    "endOffset": 18509,
                    "startOffset": 18502
                }
            },
            "secId": "s0015",
            "sentence": "Of note, we used an accelerated schedule for the two doses of MMR-containing vaccines administered in the study (42-day interval between them) since the assessment of concomitant varicella immunization included in the study\u2014and published in [15\u201317]\u2014required a 42-day interval.",
            "startOffset": 18261,
            "title": "Study design and participants"
        },
        {
            "endOffset": 19985,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Children were followed up for 10 years after receipt of their second vaccine at Day 42, with blood samplings done at Days 0, 42 and 84, and Years 1, 2, 4, 6, 8 and 10 of the study (Supplementary Fig. 1).",
            "startOffset": 19782,
            "title": "Study vaccines and procedures"
        },
        {
            "endOffset": 23236,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Antibody concentrations below the assay cut-off (i.e. 150 mIU/mL for anti-measles, 231 U/mL for anti-mumps and 4 IU/mL for anti-rubella antibodies) were given an arbitrary value of half the cut-off value.",
            "startOffset": 23032,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 33778,
            "parents": [],
            "secId": "s0055",
            "sentence": "Some children in this study received their 2 doses of MMR-containing vaccine at an interval longer than 42 days.",
            "startOffset": 33666,
            "title": "Discussion"
        },
        {
            "endOffset": 16162,
            "parents": [],
            "secId": "s0005",
            "sentence": "Mumps outbreaks, instead, can also occur in highly vaccinated communities.",
            "startOffset": 16088,
            "title": "Introduction"
        },
        {
            "endOffset": 19107,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 19046,
                    "startOffset": 19042
                }
            },
            "secId": "s0015",
            "sentence": "Inclusion criteria have been previously published [17]; they are listed in the Supplementary Materials and Methods.",
            "startOffset": 18992,
            "title": "Study design and participants"
        },
        {
            "endOffset": 26645,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Children who received the 2 doses of MMR-containing vaccine 42 days apart (groups MMRV and MMR) showed higher GMCs at Day 84 than children who received only one dose (group MMR+V).",
            "startOffset": 26465,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 36960,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 36845,
                    "startOffset": 36841
                }
            },
            "secId": "s0055",
            "sentence": "On the contrary, although a lymphoproliferative response after MMR vaccination has also been reported for the measles component, and to a lesser extent for the rubella component [34], our data did not show any antibody boost for these vaccine antigens upon a second dose of MMR-containing vaccine.",
            "startOffset": 36663,
            "title": "Discussion"
        },
        {
            "endOffset": 38463,
            "parents": [],
            "secId": "s0055",
            "sentence": "Firstly, 97.5% of the study population were white/Caucasian children.",
            "startOffset": 38394,
            "title": "Discussion"
        },
        {
            "endOffset": 37576,
            "parents": [],
            "secId": "s0055",
            "sentence": "This second dose allowed them to reach anti-mumps antibody GMCs above the seropositivity threshold, in the same range as the GMCs typically seen after a first dose at 12\u201322 months of age.",
            "startOffset": 37389,
            "title": "Discussion"
        },
        {
            "endOffset": 27134,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "As observed for MMRV and MMR groups, a decrease in GMCs was observed after receipt of this later dose 2 in the sub-groups (Fig. 4C and D).",
            "startOffset": 26996,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 27514,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Among the children in the sub-groups MMR+V 4\u20136, MMR+V 6\u20138 and MMR+V 8\u201310 who did not show an anti-mumps seroresponse after the first dose, anti-mumps antibody GMCs after the second dose of the vaccine (whenever this was administered between Year 4 and 10) were comparable to those typically seen after the first dose at 12\u201315 months of age in other groups (Supplementary Table 1).",
            "startOffset": 27134,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 38959,
            "parents": [],
            "secId": "s0055",
            "sentence": "Secondly, in this antibody persistence analysis we selected a subset of children (subset for MMR persistence) from the parent study, but two of the countries did not contribute to serological data after Year 2.",
            "startOffset": 38749,
            "title": "Discussion"
        },
        {
            "endOffset": 30031,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 30030,
                    "startOffset": 30026
                }
            },
            "secId": "s0055",
            "sentence": "In this regard, a recent study showed that post-vaccination fever\u2014which is more frequently reported after MMRV vaccination than after MMR\u2014is associated with higher antibody GMCs [22].",
            "startOffset": 29848,
            "title": "Discussion"
        },
        {
            "endOffset": 34592,
            "parents": [],
            "secId": "s0055",
            "sentence": "Although this effect in anti-rubella antibodies was visible in all sub-groups\u2014that is, regardless of when the late second dose was administered\u2014it was also of small magnitude and transient.",
            "startOffset": 34403,
            "title": "Discussion"
        },
        {
            "endOffset": 17778,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 17657,
                    "startOffset": 17650
                },
                "b0080": {
                    "endOffset": 17657,
                    "startOffset": 17650
                },
                "b0085": {
                    "endOffset": 17657,
                    "startOffset": 17650
                }
            },
            "secId": "s0005",
            "sentence": "While study design details and results for efficacy, immunogenicity and safety of the varicella-containing vaccines administered have been previously published [15\u201317], this manuscript focuses on the assessment of measles, mumps and rubella immunogenicity up to 10 years post-vaccination.",
            "startOffset": 17490,
            "title": "Introduction"
        },
        {
            "endOffset": 19384,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The vaccines administered in this study were: combined measles, mumps, rubella and varicella vaccine MMRV (Priorix-Tetra, GSK); combined measles, mumps, and rubella vaccine MMR (Priorix, GSK); and monovalent varicella vaccine (V; Varilrix, GSK).",
            "startOffset": 19139,
            "title": "Study vaccines and procedures"
        },
        {
            "endOffset": 23405,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Seropositivity rates and associated 95% confidence intervals were calculated for each group (and sub-group) and time point for anti-measles, anti-mumps and anti-rubella.",
            "startOffset": 23236,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 34776,
            "parents": [],
            "secId": "s0055",
            "sentence": "For anti-mumps, the second dose did transiently boost the antibody levels, independently of the timing of that second dose (given between 42 days and 9\u201310 years after the first dose).",
            "startOffset": 34593,
            "title": "Discussion"
        },
        {
            "endOffset": 36005,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 36004,
                    "startOffset": 35994
                },
                "b0155": {
                    "endOffset": 36004,
                    "startOffset": 35994
                },
                "b0160": {
                    "endOffset": 36004,
                    "startOffset": 35994
                },
                "b0165": {
                    "endOffset": 36004,
                    "startOffset": 35994
                }
            },
            "secId": "s0055",
            "sentence": "Some epidemiologic studies have proved that a third dose of MMR-containing vaccine given during a mumps outbreak can help protect subjects at risk, and this piece of evidence has grounded a recent recommendation from the Advisory Committee on Immunization Practices of the USA to administer a third dose of a mumps-containing vaccine, in outbreak settings, for persons at risk who were previously vaccinated with 2 doses [13,31\u201333].",
            "startOffset": 35573,
            "title": "Discussion"
        },
        {
            "endOffset": 15944,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 15943,
                    "startOffset": 15938
                },
                "b0045": {
                    "endOffset": 15943,
                    "startOffset": 15938
                }
            },
            "secId": "s0005",
            "sentence": "In the United States of America (USA), the number of outbreak cases was 349 for measles and 2,251 for mumps in 2018 (up to 29 December) [8,9].",
            "startOffset": 15802,
            "title": "Introduction"
        },
        {
            "endOffset": 30860,
            "parents": [],
            "secId": "s0055",
            "sentence": "The evolution of GMC antibody levels in the MMR group was similar to that of the other groups over time, but absolute values as of Year 4 declined below the seropositivity threshold for some individuals in the MMR group (not reflected in the group calculation for GMCs), making the seropositivity rates as of that timepoint slightly lower than in the MMRV or MMR+V groups (Fig. 3A).",
            "startOffset": 30478,
            "title": "Discussion"
        },
        {
            "endOffset": 32564,
            "parents": [],
            "secId": "s0055",
            "sentence": "The percentage of children seropositive for anti-mumps antibodies was in general lower than the seropositivity rate observed for anti-measles or anti-rubella antibodies, especially with only one dose of MMR-containing vaccine given.",
            "startOffset": 32332,
            "title": "Discussion"
        },
        {
            "endOffset": 25588,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "A second dose later in life appeared to have little or no effect on anti-measles antibody GMCs (Fig. 4B).",
            "startOffset": 25483,
            "title": "Anti-measles persistence"
        },
        {
            "endOffset": 25204,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "At Year 10, anti-measles antibody GMCs were 1857 mIU/mL in the MMRV group, 997 mIU/mL in the MMR+V group and 914 mIU/mL in the MMR group.",
            "startOffset": 25067,
            "title": "Anti-measles persistence"
        },
        {
            "endOffset": 28212,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "At Year 10, anti-rubella antibody GMCs were 19 IU/mL, 29 IU/mL and 21 IU/mL in the MMRV, MMR+V and MMR groups respectively.",
            "startOffset": 28089,
            "title": "Anti-rubella persistence"
        },
        {
            "endOffset": 18192,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "This was a phase III, observer-blind, randomized study where healthy children aged 12\u201322 months received one or two doses of MMR-containing vaccines with or without concomitant varicella immunization.",
            "startOffset": 17992,
            "title": "Study design and participants"
        },
        {
            "endOffset": 24770,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Some children in the MMR+V group received a second dose of MMR-containing vaccine after Year 4 (subgroups MMR+V 4\u20136, MMR+V 6\u20138 and MMR+V 8\u201310).",
            "startOffset": 24627,
            "title": "Anti-measles persistence"
        },
        {
            "endOffset": 16087,
            "parents": [],
            "secId": "s0005",
            "sentence": "Measles outbreaks occur mostly in unvaccinated individuals, thus a high vaccination coverage is the most important goal to prevent the disease.",
            "startOffset": 15944,
            "title": "Introduction"
        },
        {
            "endOffset": 26206,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Similarly to the GMCS, in the MMR+V 4\u20136, MMR+V 6\u20138 and MMR+V 8\u201310 subgroups the seropositivity rates increased to \u2265 98.6% after receipt of their (later) second dose (Fig. 3D).",
            "startOffset": 26031,
            "title": "Anti-mumps persistence"
        },
        {
            "endOffset": 28947,
            "parents": [],
            "secId": "s0055",
            "sentence": "This analysis showed that two doses of MMRV or 1 or 2 doses of MMR given to children in their second year of life induced antibody responses against measles, mumps and rubella viruses that persisted for up to 10 years post-vaccination.",
            "startOffset": 28712,
            "title": "Discussion"
        },
        {
            "endOffset": 36256,
            "parents": [],
            "secId": "s0055",
            "sentence": "Interestingly, in these epidemiologic studies not only did a third dose of the vaccine help protect subjects at risk, but it also elicited a boost in anti-mumps antibody titers similar to what we observed in our study upon a second dose after Year 4.",
            "startOffset": 36006,
            "title": "Discussion"
        },
        {
            "endOffset": 37142,
            "parents": [],
            "secId": "s0055",
            "sentence": "In any case, the lack of an established correlate of protection for mumps vaccines based on antibody titers makes it difficult to interpret the clinical impact of such boostability.",
            "startOffset": 36961,
            "title": "Discussion"
        },
        {
            "endOffset": 24985,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "At Year 10 after vaccination, \u226594.0% of children were still seropositive for anti-measles antibody.",
            "startOffset": 24886,
            "title": "Anti-measles persistence"
        },
        {
            "endOffset": 37388,
            "parents": [],
            "secId": "s0055",
            "sentence": "Even though some children in the MMR+V group in our study did not show an anti-mumps seroresponse after the first dose of MMR-containing vaccine administered at 12\u201322 months of age, all of them responded when a second dose was given after Year 4.",
            "startOffset": 37142,
            "title": "Discussion"
        },
        {
            "endOffset": 25314,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "The highest anti-measles antibody concentrations were observed, at all time points tested, in the MMRV group.",
            "startOffset": 25205,
            "title": "Anti-measles persistence"
        },
        {
            "endOffset": 28088,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "After that point, antibody concentrations decreased gradually over time in MMRV, MMR+V and MMR groups, except for a sustainment of the levels at Year 1 in the MMR group and a small increase at Year 10 in the MMR+V group (Fig. 4E).",
            "startOffset": 27858,
            "title": "Anti-rubella persistence"
        },
        {
            "endOffset": 34036,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, and according to their country\u2019s vaccination schedule, they received a second dose of MMR-containing vaccine (not planned in the study) after Year 4.",
            "startOffset": 33878,
            "title": "Discussion"
        },
        {
            "endOffset": 23669,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Seropositivity rate was defined as the percentage of participants with antibody concentration greater than or equal to the seropositivity threshold for each assay (i.e. 150 mIU/mL for anti-measles, 231 U/mL for anti-mumps and 4 IU/mL for anti-rubella antibodies).",
            "startOffset": 23406,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 22018,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Serological data from any subject who received an additional dose of MMR- or varicella-containing vaccines after Day 84 were censored from the day of additional dose receipt onwards for the main persistence analyses.",
            "startOffset": 21802,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 30263,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 30129,
                    "startOffset": 30125
                }
            },
            "secId": "s0055",
            "sentence": "In agreement with this observation, in the previously published safety results of this study [17] we also found a higher rate of post-vaccination fever in children of the MMRV group compared to the rates observed in the MMR groups.",
            "startOffset": 30032,
            "title": "Discussion"
        },
        {
            "endOffset": 39206,
            "parents": [],
            "secId": "s0055",
            "sentence": "Thirdly, the number of children for whom results were available decreased over time.",
            "startOffset": 39122,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19309405",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "stephane.x.carryn@gsk.com",
                "first": "Stephane",
                "initial": "S.",
                "last": "Carryn"
            },
            {
                "email": "muriel.m.feyssaguet@gsk.com",
                "first": "Muriel",
                "initial": "M.",
                "last": "Feyssaguet"
            },
            {
                "email": "michael.x.povey@gsk.com",
                "first": "Michael",
                "initial": "M.",
                "last": "Povey"
            },
            {
                "email": "emmanuel.di-paolo@gsk.com",
                "first": "Emmanuel",
                "initial": "E.",
                "last": "Di Paolo"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.07.049",
        "firstpage": "5323",
        "issn": "0264410X",
        "keywords": [
            "Booster effect",
            "Immunogenicity",
            "Long-term antibody persistence",
            "Measles, mumps and rubella vaccine"
        ],
        "lastpage": "5331",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up"
    }
}